100 results on '"Tracy, M."'
Search Results
2. 602 Fetal ‘late bloomers’ – factors and outcomes associated with apparent resolution of fetal growth restriction
3. 145 Acute treatment of severe hypertension in pregnancies with fetal growth restriction: Does medication choice matter?
4. Fetal growth restriction or small for gestational age? Consideration of biometry alone and criteria performance
5. Assessment of adverse perinatal outcomes among “small” fetuses not meeting the Delphi criteria: accounting for confounders
6. Risk of adverse perinatal outcomes in pregnancies with ‘small’ fetuses not meeting Delphi consensus criteria for fetal growth restriction
7. Prediction of pregnancy duration up to 34 weeks gestation after ultrasound-indicated cerclage placement
8. Predictors of pregnancy duration among women undergoing exam-indicated cerclage: a survival analysis approach
9. Characteristics associated with previable delivery and/or delivery <21 days after transvaginal cervical cerclage placement
10. Efficacy of acute antihypertensive therapy on resolution of severe hypertension relative to prior oral regimen
11. Predictors of pregnancy duration among women undergoing exam-indicated cerclage: a survival analysis approach
12. Prediction of pregnancy duration up to 34 weeks gestation after ultrasound-indicated cerclage placement
13. Characteristics associated with previable delivery and/or delivery <21 days after transvaginal cervical cerclage placement
14. The timing of administration of antenatal corticosteroids in women with indicated preterm birth
15. Efficacy of acute antihypertensive therapy on resolution of severe hypertension relative to prior oral regimen
16. Analysis of characteristics associated with the need for cervical cerclage revision
17. Growth velocity and severe maternal morbidity in pregnancies complicated by fetal growth restriction
18. Risk factors for postpartum readmission with severe hypertension within the first 21 days after delivery
19. Risk of adverse outcomes for small fetuses not meeting consensus criteria for fetal growth restriction
20. The use of cervical sonography to differentiate true from false labor in term patients presenting for labor check
21. Growth velocity and severe maternal morbidity in pregnancies complicated by fetal growth restriction
22. Risk of adverse outcomes for small fetuses not meeting consensus criteria for fetal growth restriction
23. 934 Factors associated with acute response to treatment of severe hypertension in pregnancy
24. 305 A predictive index for severe adverse perinatal outcomes in pregnancies complicated by fetal growth restriction
25. 998 Fetal growth restriction and the association between abnormal placental changes and significant adverse neonatal outcomes
26. 304 Predicting severe adverse perinatal outcomes in pregnancies complicated by fetal growth restriction: a validation study
27. 824 Prediction of perinatal demise and severe adverse neonatal outcomes in pregnancies with fetal growth restriction
28. Risk factors for postpartum readmission with severe hypertension within the first 21 days after delivery
29. Analysis of characteristics associated with the need for cervical cerclage revision
30. 305 A predictive index for severe adverse perinatal outcomes in pregnancies complicated by fetal growth restriction
31. 934 Factors associated with acute response to treatment of severe hypertension in pregnancy
32. 998 Fetal growth restriction and the association between abnormal placental changes and significant adverse neonatal outcomes
33. 824 Prediction of perinatal demise and severe adverse neonatal outcomes in pregnancies with fetal growth restriction
34. Discussion: ‘Predictive value of lung-head ratio in congenital diaphragmatic hernia’ by Yang et al
35. Prenatal screening for Down syndrome should focus on safety more than cost-effectiveness
36. 304 Predicting severe adverse perinatal outcomes in pregnancies complicated by fetal growth restriction: a validation study
37. 928: Use of 17-α-hydroxyprogesterone-caproate did not predict pregnancy prolongation in women with prior spontaneous preterm birth
38. 1170: Validiation of the MFMU admission model for vaginal birth after cesarean in a modern population
39. 276: Inpatient management protocol reduces racial disparity in treatment of severe maternal hypertension
40. 712: Intrapartum variables predicting labor progress and vaginal delivery in trials of labor after cesarean
41. 1137: At what blood pressures do hypertensive women develop severe maternal morbidity: the clinical inflection point
42. 276: Inpatient management protocol reduces racial disparity in treatment of severe maternal hypertension
43. 216: Can prediction of vaginal birth after cesarean at admission for delivery be improved?
44. 712: Intrapartum variables predicting labor progress and vaginal delivery in trials of labor after cesarean
45. 928: Use of 17-α-hydroxyprogesterone-caproate did not predict pregnancy prolongation in women with prior spontaneous preterm birth
46. 1137: At what blood pressures do hypertensive women develop severe maternal morbidity: the clinical inflection point
47. 1170: Validiation of the MFMU admission model for vaginal birth after cesarean in a modern population
48. 491: Will my baby be big? A new index for predicting fetal overgrowth in diabetic mothers
49. 809: Validity of the MFMU antenatal VBAC ‘calculator’ in the contemporary labor management era
50. 216: Can prediction of vaginal birth after cesarean at admission for delivery be improved?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.